- call +1-201-465-4211
- email sales@mrinsights.biz
In medicine, a biomarker is a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism.
Scope of the Report:
This report studies the Metabolic Biomarker Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Metabolic Biomarker Testing market by product type and applications/end industries.
Biomarkers are useful in a number of ways, including measuring the progress of disease, evaluating the most effective therapeutic regimes for a particular cancer type, and establishing long-term susceptibility to cancer or its recurrence. The parameter can be chemical, physical or biological. Biomarkers help in early diagnosis, disease prevention, drug target identification, drug response etc. Several biomarkers have been identified for many diseases such as serum LDL for cholesterol, blood pressure, and P53 gene[4]and MMPs [5] as tumor markers for cancer. Biomarkers are also seen as the key to personalised medicine, treatments individually tailored to specific patients for highly efficient intervention in disease processes. Often, such biomarkers indicate changes in metabolic processes.
The global Metabolic Biomarker Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Metabolic Biomarker Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Agilent Technologies
Bio-Rad Laboratories
Bruker
Danaher
Waters Corporation
Thermo Fisher Scientific
Biocrates Life Sciences
Human Metabolome Technologies
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Separation Techniques
Detection Techniques
Others
Market Segment by Applications, can be divided into
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Metabolic Biomarker Testing Market Overview
1.1 Product Overview and Scope of Metabolic Biomarker Testing
1.2 Classification of Metabolic Biomarker Testing by Types
1.2.1 Global Metabolic Biomarker Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Metabolic Biomarker Testing Revenue Market Share by Types in 2017
1.2.3 Separation Techniques
1.2.4 Detection Techniques
1.2.5 Others
1.3 Global Metabolic Biomarker Testing Market by Application
1.3.1 Global Metabolic Biomarker Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Drug Discovery
1.3.3 Nutrigenomics
1.3.4 Toxicology Testing
1.3.5 Personalized Medicine
1.3.6 Functional Genomics
1.4 Global Metabolic Biomarker Testing Market by Regions
1.4.1 Global Metabolic Biomarker Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Metabolic Biomarker Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Metabolic Biomarker Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Metabolic Biomarker Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Metabolic Biomarker Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Metabolic Biomarker Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Metabolic Biomarker Testing (2013-2023)
2 Manufacturers Profiles
2.1 Agilent Technologies
2.1.1 Business Overview
2.1.2 Metabolic Biomarker Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Agilent Technologies Metabolic Biomarker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bio-Rad Laboratories
2.2.1 Business Overview
2.2.2 Metabolic Biomarker Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bio-Rad Laboratories Metabolic Biomarker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bruker
2.3.1 Business Overview
2.3.2 Metabolic Biomarker Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bruker Metabolic Biomarker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Danaher
2.4.1 Business Overview
2.4.2 Metabolic Biomarker Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Danaher Metabolic Biomarker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Waters Corporation
2.5.1 Business Overview
2.5.2 Metabolic Biomarker Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Waters Corporation Metabolic Biomarker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Thermo Fisher Scientific
2.6.1 Business Overview
2.6.2 Metabolic Biomarker Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Thermo Fisher Scientific Metabolic Biomarker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Biocrates Life Sciences
2.7.1 Business Overview
2.7.2 Metabolic Biomarker Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Biocrates Life Sciences Metabolic Biomarker Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Human Metabolome Technologies
2.8.1 Business Overview
2.8.2 Metabolic Biomarker Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Human Metabolome Technologies Metabolic Biomarker Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Metabolic Biomarker Testing Market Competition, by Players
3.1 Global Metabolic Biomarker Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Metabolic Biomarker Testing Players Market Share
3.2.2 Top 10 Metabolic Biomarker Testing Players Market Share
3.3 Market Competition Trend
4 Global Metabolic Biomarker Testing Market Size by Regions
4.1 Global Metabolic Biomarker Testing Revenue and Market Share by Regions
4.2 North America Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
4.5 South America Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
5 North America Metabolic Biomarker Testing Revenue by Countries
5.1 North America Metabolic Biomarker Testing Revenue by Countries (2013-2018)
5.2 USA Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
6 Europe Metabolic Biomarker Testing Revenue by Countries
6.1 Europe Metabolic Biomarker Testing Revenue by Countries (2013-2018)
6.2 Germany Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
6.3 UK Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
6.4 France Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Metabolic Biomarker Testing Revenue by Countries
7.1 Asia-Pacific Metabolic Biomarker Testing Revenue by Countries (2013-2018)
7.2 China Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
7.5 India Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
8 South America Metabolic Biomarker Testing Revenue by Countries
8.1 South America Metabolic Biomarker Testing Revenue by Countries (2013-2018)
8.2 Brazil Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Metabolic Biomarker Testing by Countries
9.1 Middle East and Africa Metabolic Biomarker Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Metabolic Biomarker Testing Revenue and Growth Rate (2013-2018)
10 Global Metabolic Biomarker Testing Market Segment by Type
10.1 Global Metabolic Biomarker Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Metabolic Biomarker Testing Market Forecast by Type (2018-2023)
10.3 Separation Techniques Revenue Growth Rate (2013-2023)
10.4 Detection Techniques Revenue Growth Rate (2013-2023)
10.5 Others Revenue Growth Rate (2013-2023)
11 Global Metabolic Biomarker Testing Market Segment by Application
11.1 Global Metabolic Biomarker Testing Revenue Market Share by Application (2013-2018)
11.2 Metabolic Biomarker Testing Market Forecast by Application (2018-2023)
11.3 Drug Discovery Revenue Growth (2013-2018)
11.4 Nutrigenomics Revenue Growth (2013-2018)
11.5 Toxicology Testing Revenue Growth (2013-2018)
11.6 Personalized Medicine Revenue Growth (2013-2018)
11.7 Functional Genomics Revenue Growth (2013-2018)
12 Global Metabolic Biomarker Testing Market Size Forecast (2018-2023)
12.1 Global Metabolic Biomarker Testing Market Size Forecast (2018-2023)
12.2 Global Metabolic Biomarker Testing Market Forecast by Regions (2018-2023)
12.3 North America Metabolic Biomarker Testing Revenue Market Forecast (2018-2023)
12.4 Europe Metabolic Biomarker Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Metabolic Biomarker Testing Revenue Market Forecast (2018-2023)
12.6 South America Metabolic Biomarker Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Metabolic Biomarker Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Metabolic Biomarker Testing Picture
Table Product Specifications of Metabolic Biomarker Testing
Table Global Metabolic Biomarker Testing and Revenue (Million USD) Ma
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
